» Articles » PMID: 25486354

Why Genes Extending Lifespan in Model Organisms Have Not Been Consistently Associated with Human Longevity and What It Means to Translation Research

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2014 Dec 9
PMID 25486354
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

A recent paper by Deelen et al. (2014) in Human Molecular Genetics reports the largest genome-wide association study of human longevity to date. While impressive, there is a remarkable lack of association of genes known to considerably extend lifespan in rodents with human longevity, both in this latest study and in genetic association studies in general. Here, I discuss several possible explanations, such as intrinsic limitations in longevity association studies and the complex genetic architecture of longevity. Yet one hypothesis is that the lack of correlation between longevity-associated genes in model organisms and genes associated with human longevity is, at least partly, due to intrinsic limitations and biases in animal studies. In particular, most studies in model organisms are conducted in strains of limited genetic diversity which are then not applicable to human populations. This has important implications and, together with other recent results demonstrating strain-specific longevity effects in rodents due to caloric restriction, it questions our capacity to translate the exciting findings from the genetics of aging to human therapies.

Citing Articles

Climbing the longevity pyramid: overview of evidence-driven healthcare prevention strategies for human longevity.

Martinovic A, Mantovani M, Trpchevska N, Novak E, Milev N, Bode L Front Aging. 2024; 5:1495029.

PMID: 39659760 PMC: 11628525. DOI: 10.3389/fragi.2024.1495029.


Systems biology approaches identify metabolic signatures of dietary lifespan and healthspan across species.

Hilsabeck T, Narayan V, Wilson K, Carrera E, Raftery D, Promislow D Nat Commun. 2024; 15(1):9330.

PMID: 39472442 PMC: 11522498. DOI: 10.1038/s41467-024-52909-y.


Pharmacology of Aging: as a Tool to Validate Drug Targets for Healthy Lifespan.

Dos Santos E, Cocheme H Aging Biol. 2024; 2(1):20240034.

PMID: 39346601 PMC: 7616647. DOI: 10.59368/agingbio.20240034.


Repurposing effect of cardiovascular-metabolic drug to increase lifespan: a systematic review of animal studies and current clinical trial progress.

Barinda A, Hardi H, Louisa M, Khatimah N, Marliau R, Felix I Front Pharmacol. 2024; 15:1373458.

PMID: 38966557 PMC: 11223003. DOI: 10.3389/fphar.2024.1373458.


Seven knowledge gaps in modern biogerontology.

Rattan S Biogerontology. 2024; 25(1):1-8.

PMID: 38206540 DOI: 10.1007/s10522-023-10089-0.


References
1.
Deak F, Sonntag W . Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012; 67(6):611-25. PMC: 3348499. DOI: 10.1093/gerona/gls118. View

2.
Budovsky A, Craig T, Wang J, Tacutu R, Csordas A, Lourenco J . LongevityMap: a database of human genetic variants associated with longevity. Trends Genet. 2013; 29(10):559-60. DOI: 10.1016/j.tig.2013.08.003. View

3.
Roubenoff R, Parise H, Payette H, Abad L, DAgostino R, Jacques P . Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003; 115(6):429-35. DOI: 10.1016/j.amjmed.2003.05.001. View

4.
Liao C, Rikke B, Johnson T, Diaz V, Nelson J . Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell. 2009; 9(1):92-5. PMC: 3476836. DOI: 10.1111/j.1474-9726.2009.00533.x. View

5.
de Magalhaes J, Wuttke D, Wood S, Plank M, Vora C . Genome-environment interactions that modulate aging: powerful targets for drug discovery. Pharmacol Rev. 2011; 64(1):88-101. PMC: 3250080. DOI: 10.1124/pr.110.004499. View